The failure of cancer therapy is largely driven by the remarkable capacity of tumor cells to adapt to pharmacological stress. Beyond genetic alterations and signaling pathway rewiring, malignant cells exploit dynamic stress-adaptive protein states that promote survival under cytotoxic conditions. Rather than providing...
Amr A. El-Sehrawy, A. A. Raeef, Mirza R. Baig et al.· European Journal of Pharmaco...· 0 citations
Nanoparticles have emerged as versatile materials with unique physicochemical characteristics that differ from their bulk counterparts, enabling their integration across scientific, industrial, and biomedical domains. This review provides a unified perspective on the classification, synthesis, characterization, and...
Manik Dhiman, B. Kaur, Nishant Thakur et al.· Drug Delivery Letters· 0 citations
Artificial intelligence research in pancreatic cancer is growing rapidly and becoming increasingly multidisciplinary, although productivity and collaboration remain uneven.
Pegah Rashidian, A. Smerat, Mohammad Ahmar Khan et al.· Medicine· 0 citations
The article critically analyzes methods for exosome isolation, loading strategies into hydrogel matrices, and essential characterization techniques to ensure vesicle integrity and predict in vivo performance, and highlights the compelling therapeutic efficacy of this synergistic platform across diverse regenerative app...
Elaheh Esmaeili, Iman Rad, Saied Soflaei et al.· Journal of Polymers and the...· 0 citations
A stage-dependent conceptual framework linking beta-cell stress, innate immune activation, and TLS-mediated stabilization of chronic inflammation is presented, providing a rationale for the limited durability of current immune-targeted therapies and identifying experimentally testable hypotheses.
T. Alramadneh, Aziz Kubaev, Shakir Mahmood Saeed et al.· Diabetes Research and Clinic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.